CD4 and mitochondrial DNA depletion syndrome 4a: Currently, PEPFAR supports limited CD4 testing among targeted groups receiving AHD services in HIV service delivery facilities, among PLHIV at presentation in areas with high AHD prevalence, or among individuals aged ≥ 5 years who have documented viremia despite receiving ART for more than a year [1, 12].